InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.69+0.04 (+5.48%)
Close on Nov 18, 2026Market cap $31.87MP/E –Yield –
InspireMD net income
Net income is the profit left for shareholders after every expense, interest and tax.
InspireMD's net income for the twelve months ending Jun 30, 2026 was -$52.48M. For fiscal 2025 it was -$48.79M. The highest annual figure on record is -$2.72M in fiscal 2009.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$48.79M | – |
| FY2024 | Dec 31, 2024 | -$32.01M | – |
| FY2023 | Dec 31, 2023 | -$19.92M | – |
| FY2022 | Dec 31, 2022 | -$18.49M | – |
| FY2021 | Dec 31, 2021 | -$14.92M | – |
| FY2020 | Dec 31, 2020 | -$10.54M | – |
| FY2019 | Dec 31, 2019 | -$10.04M | – |
| FY2018 | Dec 31, 2018 | -$7.24M | – |
| FY2017 | Dec 31, 2017 | -$8.44M | – |
| FY2016 | Dec 31, 2016 | -$8.46M | – |
| FY2015 | Dec 31, 2015 | -$15.59M | – |
| FY2013 | Jun 30, 2013 | -$29.26M | – |
| FY2010 | Dec 31, 2010 | -$3.42M | – |
| FY2009 | Dec 31, 2009 | -$2.72M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.32M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.69M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$12.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.17M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.89M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.08M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.26M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.48M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.10M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.07M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.51M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.24M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.85M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.98M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.56M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.07M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.21M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.21M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.21M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.01M | – |
| Q2 FY2018 | Jun 30, 2018 | -$627.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.39M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.50M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.09M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.29M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.27M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.00M | – |
See a number that looks wrong?